Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company focused on precision medicine. The Director of Upstream Product Marketing – Early Stage PSMA is responsible for shaping the commercial strategy for next-generation diagnostic products, leading opportunity identification, and guiding the strategic direction of Telix’s PSMA innovation pipeline.
Responsibilities:
- Lead regional opportunity and identification for new PSMA imaging concepts aligned with Telix’s long-term franchise and portfolio strategy
- Direct comprehensive market assessments to quantify unmet needs, commercial potential, and competitive advantage
- Own the development of early commercial strategy, articulating long-range positioning, market differentiation, and value creation pathways
- Define and guide Target Product Profiles (TPPs) in collaboration with GDLs and Medical Affairs to ensure development programs are grounded in customer and market needs
- Engage regional leaders to gather, analyze, and integrate early customer insights that shape development priorities and early-stage decision-making
- Lead the creation of high-quality, strategic business cases for early PSMA opportunities, including TAM/SAM models, adoption scenarios, and value assessments
- Collaborate with Commercial Strategy & Operations to develop and challenge early financial models, forecasts, and scenario planning
- Shape early pricing, access, and reimbursement assumptions to ensure commercial feasibility
- Present strategic recommendations to leadership, governing bodies, and PMC pre-review forums to influence go/no-go investment decisions
- Ensure early-stage programs are well-prepared for seamless transition into late-stage development
- Serve as the senior commercial lead for early-stage PSMA programs, ensuring commercial guidance is deeply integrated into clinical and regulatory strategies
- Partner with GDLs, Medical Affairs, and Clinical Development to influence protocol direction and evidence-generation priorities
- Lead alignment across regions, ensuring early-stage insights, voice-of-customer (VoC), and market requirements are consistently communicated and embedded in development planning
- Provide early strategic guidance to downstream marketing teams to facilitate long-term brand and launch planning
- Provide competitive intelligence and foresight on emerging PSMA technologies, clinical trends, and pipeline dynamics
- Identify early opportunities and risks that could influence Telix’s future positioning, lifecycle strategy, or partnership pathways
- Develop strategic dashboards and intelligence briefs for senior leadership to support portfolio decisions
- Collaborate with Corporate Strategy and BD on partnership evaluations, external innovation scans, and potential licensing opportunities
- Lead cross-functional strategic initiatives and early-stage commercial workstreams, ensuring disciplined execution and timely delivery
- Manage governance routines, executive updates, and decision-making materials for early development and portfolio prioritization
- Provide commercial rigor, clear risk-benefit evaluation, and customer-driven rationale to support strategic prioritization across the pipeline
Requirements:
- Bachelor's degree in Marketing, Business, Life Sciences, or related field; MBA or advanced degree strongly preferred
- 8–12+ years of relevant experience in pharmaceutical, biotech, diagnostics, business development, or strategic marketing
- Significant experience in upstream, early product strategy, or franchise-level portfolio planning—preferably in oncology, urology, or molecular imaging
- Strong analytical capabilities with demonstrated expertise in forecasting, TAM/SAM modeling, and business case development
- Proven ability to translate complex scientific, clinical, and market insights into actionable commercial strategy
- Demonstrated leadership and influence across matrixed organizations
- Exceptional communication skills, with the ability to present recommendations to senior and executive leadership
- Strong program leadership, prioritization, and decision-making skills in fast-paced environments
- Travel: 35% - 50%, conservatively